FOR IMMEDIATE RELEASE
March 8, 2001
Parents who worry that their household cat might trigger asthma in their children shouldn't be too quick to get rid of the pet, according to a study that appears in the March 10 issue of The Lancet. The study shows that high levels of cat allergen in the home decrease the risk of asthma, apparently by altering the immune response to cats.
The study, funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), begins to uncover the immune system processes behind this phenomenon. This work was also supported by the National Institute of Environmental Health Sciences (NIEHS).
For many allergens, such as the house dust mite, the higher the level of exposure, the higher the likelihood of a person producing "allergic" antibodies (called immunglobulin E or IgE antibodies). High allergen levels also increase a person's risk of becoming allergic and developing asthma.
Thomas A. Platts-Mills, M.D., Ph.D., and colleagues at the University of Virginia's Asthma and Allergic Diseases Center have shown that cat exposure is different. The researchers measured the levels of antibodies to cat allergen in 226 children, aged 12 to 14 years, and tested the children for asthma. They also measured the amount of cat allergens in the children's homes and discovered that low-to-moderate amounts of cat allergen seemed to trigger allergy, but high amounts reduced both IgE antibodies and the likelihood of asthma.
"This result alters the advice we give patients," says Dr. Platts-Mills. "I would not recommend that parents get rid of their cat because they are concerned their child might develop asthma. However, high exposure to cat allergen appears to be protective for some children and a risk factor for others. If the child is wheezing and has a positive skin test to cat allergen, then you should get rid of your cat."
The high levels of cat allergen prompted the children's immune systems to predominantly make immunoglobulin G (IgG) and IgG4 antibodies rather than IgE, explains Marshall Plaut, M.D., chief of the allergic mechanisms section at NIAID. "This research sheds more light on the relationship between allergen exposure and asthma. When investigators further understand this process, it might lead to new treatments for asthma."
Resources for Patients:
Airborne Allergens: Something in the Air
For additional information about allergy, including clinical trials of experimental treatments, see the allergy information available from MEDLINEplus.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of
infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News
releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research,
and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health ®
back to top
Last Updated March 08, 2001